profit from every SEK 100 of sales.
SEK 0SEK 100
Ambea
SEK 195.50+0.51% today
+40.7% in 1 year
1-year low SEK 113.801-year high SEK 195.50
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay SEK 24.54 for every SEK 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Ambea sold, what it kept, and what it did with the cash.
Sales went from SEK 12.6 billion in 2022 to SEK 16.0 billion in 2025, with SEK 665 million of profit last year.
SalesProfit
Ambea handed back 33% of the cash it generated last year.
Buybacks SEK 485MSEK 185M
Free cash flow 2025SEK 2.0B
Bought back its own sharesSEK 485M
Paid as dividendsSEK 185M
Cash vs. debtSEK 133M vs. SEK 12.6B
Ambea vs. similar companies
Ambea grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from SEK 100 of sales | Sales growth a year | Price per SEK 1 of profit |
|---|---|---|---|
| Ambea | 24.5× · Fair price | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads Ambea's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 12,635 | 13,312 | 14,195 | 16,039 | |
| 12,192 | 12,847 | 13,703 | 15,483 | |
| 843 | 975 | 1,255 | 1,360 | |
| 2,003 | 2,251 | 2,618 | 2,846 | |
| 366 | 455 | 620 | 665 | |
| 3.89 | 5.07 | 7.20 | 7.92 | |
| 96.5% | 96.5% | 96.5% | 96.5% | |
| 6.7% | 7.3% | 8.8% | 8.5% | |
| 2.9% | 3.4% | 4.4% | 4.1% |
Balance sheet
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17,875 | 17,893 | 18,177 | 20,475 |
| Cash | 259 | 6 | 28 | 133 |
| Total debt | 10,959 | 10,745 | 10,757 | 12,643 |
| Total liabilities | 13,194 | 12,973 | 13,191 | 15,275 |
| 4,681 | 4,920 | 4,986 | 5,200 | |
| 94 | 90 | 86 | 84 | |
| 4.1% | 4.8% | 6.3% | 6.0% | |
| 7.8% | 9.2% | 12.4% | 12.8% |
Cash flow
| In millions of SEK | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,440 | 1,714 | 2,066 | 2,169 | |
| 105 | 90 | 117 | 139 | |
| 1,335 | 1,624 | 1,949 | 2,030 | |
| Dividends paid | 109 | 112 | 130 | 185 |
| 179 | 47 | 431 | 485 | |
| – | – | – | – |
Valuation
- 24.5×
- –
- 0.92
- 2.2×
- 1.0×
- 8.0×
- 10.1×
- 12.4%
- 4.1%
- 1.1%
Profitability
- 96.5%
- 8.5%
- 4.1%
- –
- 6.0%
- 5.3%
- –
- –
- –
- –
Growth
- +8.3%
- +26.7%
- –
- –
- −3.7%
Financial health
- 4.4×
- 2.43
- –
- 2.8×
- 0.41
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 46%of 946
Bottom 49%of 871
Top 42%of 563
Bottom 40%of 867
Top 5%of 986
1.1%of the share price, paid each year
On $1,000 invested$11a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
27.8% of its profit
Room to growStretchedMore than it earns: 9.1%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
46No pass
Benjamin Graham
42No pass
Philip Fisher
64Pass
Peter Lynch
68Pass
Joel Greenblatt
22No pass
Charlie Munger
35No pass
Terry Smith
35No pass
Questions about Ambea
Is Ambea a good stock to buy?
A business with weak numbers at a fair price. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Ambea AI analysis
What does Ambea do?
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. It is in Medical Care Facilities, based in Solna, Sweden, with 41,000 employees.
Does Ambea pay a dividend?
Yes. At today's price the dividend is 1.1% a year, about 28% of its yearly profit. In 2025 it paid out SEK 185 million in dividends.
Is Ambea stock halal?
No. Ambea does not pass our halal screen: its debt is 78% of its market value, at or above the 33% limit. How we check
How has Ambea stock done over the past year?
Up 40.7% over the past twelve months, to SEK 195.50. It traded between SEK 113.80 and SEK 195.50, close to its high.
Who are Ambea's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Ambea's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.